Orally Administered Eicosapentaenoic Acid Induces Rapid Regression of Atherosclerosis Via Modulating the Phenotype of Dendritic Cells in LDL Receptor-Deficient Mice | Zendy

Kenji Nakajima | Zendy; Tomoya Yamashita | Zendy; Tomoyuki Kita | Zendy; Masafumi Takeda | Zendy; Naoto Sasaki | Zendy; Kazuyuki Kasahara | Zendy; Masakazu Shinohara | Zendy; Yoshiyuki Rikitake | Zendy; Tatsuro Ishida | Zendy; Mitsuhiro Yokoyama | Zendy; Ken–ichi Hirata | Zendy

Open Access

Orally Administered Eicosapentaenoic Acid Induces Rapid Regression of Atherosclerosis Via Modulating the Phenotype of Dendritic Cells in LDL Receptor-Deficient Mice

Author(s) -

Kenji Nakajima,

Tomoya Yamashita,

Tomoyuki Kita,

Masafumi Takeda,

Naoto Sasaki,

Kazuyuki Kasahara,

Masakazu Shinohara,

Yoshiyuki Rikitake,

Tatsuro Ishida,

Mitsuhiro Yokoyama,

Ken–ichi Hirata

Publication year - 2011

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.111.229443

Subject(s) - eicosapentaenoic acid , cd86 , medicine , cd11c , endocrinology , cd80 , cholesterol , phenotype , receptor , ldl receptor , immunology , polyunsaturated fatty acid , immune system , lipoprotein , cd40 , biology , t cell , fatty acid , cytotoxic t cell , in vitro , biochemistry , gene

Eicosapentaenoic acid (EPA) has been shown to have beneficial effects on cardiovascular diseases, although the precise mechanism is unknown. We investigated the effect of EPA on the regression of atherosclerosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research